ID   HIOAnu
AC   CVCL_X937
SY   HIOA
DR   CGH-DB; 379-2
DR   CGH-DB; 9354-4
DR   Wikidata; Q54889585
RX   CelloPub=CLPUB00153;
RX   PubMed=11330945;
RX   PubMed=12417041;
RX   PubMed=17671176;
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft produced in a BALB-c/nu nude mouse.
CC   Doubling time: 34 hours (CelloPub=CLPUB00153).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
RX   CelloPub=CLPUB00153;
RA   Iguchi M., Ishiwata I., Kiguchi K., Tokieda Y., Soma M., Ishikawa H.;
RT   "Establishment and characterization of the ovarian endometrioid
RT   carcinoma cell line (HIOAnu).";
RL   Hum. Cell 13 Suppl. 2:50.2-50.2(2000).
//
RX   PubMed=11330945; DOI=10.1006/gyno.2001.6132;
RA   Watanabe T., Imoto I., Kosugi Y., Ishiwata I., Inoue S., Takayama M.,
RA   Sato A., Inazawa J.;
RT   "A novel amplification at 17q21-23 in ovarian cancer cell lines
RT   detected by comparative genomic hybridization.";
RL   Gynecol. Oncol. 81:172-177(2001).
//
RX   PubMed=12417041; DOI=10.1111/j.1349-7006.2002.tb01213.x; PMCID=PMC5926887;
RA   Watanabe T., Imoto I., Katahira T., Hirasawa A., Ishiwata I., Emi M.,
RA   Takayama M., Sato A., Inazawa J.;
RT   "Differentially regulated genes as putative targets of amplifications
RT   at 20q in ovarian cancers.";
RL   Jpn. J. Cancer Res. 93:1114-1122(2002).
//
RX   PubMed=17671176; DOI=10.1158/0008-5472.CAN-06-4567;
RA   Kikuchi R., Tsuda H., Kanai Y., Kasamatsu T., Sengoku K.,
RA   Hirohashi S., Inazawa J., Imoto I.;
RT   "Promoter hypermethylation contributes to frequent inactivation of a
RT   putative conditional tumor suppressor gene connective tissue growth
RT   factor in ovarian cancer.";
RL   Cancer Res. 67:7095-7105(2007).
//